Cordova, TN, United States of America

John Myers Zanella

This inventor holds 31 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Biodegradable Drug Delivery. Top assignees: Warsaw Orthopedic, Inc., Medtronic, Inc.. Active years: 2009-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Myers Zanella. Retrieved from https://idiyas.com/inventor/john-myers-zanella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 93.5


 

Average Co-Inventor Count = 2.9

ph-index = 11

Forward Citations = 267(Granted Patents)


Location History:

  • Memphis, TN (US) (2011 - 2013)
  • Cordova, TN (US) (2009 - 2018)

Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biodegradable Polymer
Therapeutic Agents
Drug Delivery
Clonidine
Dexamethasone
Pharmaceutical Gels
Pain Treatment
Alpha Agonists
Osteograft
Drug Depot
Directional Delivery
Inflammation
31 patents (USPTO):Explore Patents

Title: Innovations by John Myers Zanella: Pioneering Pain Relief Solutions

Introduction

John Myers Zanella, based in Cordova, TN, is a prolific inventor with an impressive portfolio of 31 patents. His contributions to the field of biomedical engineering, particularly in pain management, have paved the way for novel treatment methodologies utilizing advanced pharmaceutical technologies.

Latest Patents

Zanella's latest patents include significant innovations such as "Clonidine and GABA compounds in a biodegradable polymer carrier," which provide effective treatments for extended periods. This patent addresses pain caused by various sources, including spinal disc herniation (sciatica), spondylolisthesis, and post-surgical pain. By administering clonidine and gamma-aminobutyric acid near the target site, patients can experience relief lasting anywhere from three days to an impressive 180 days, due to the use of biodegradable polymers.

Another notable patent is for "Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin." This innovative gel adheres to target tissue beneath the skin, allowing for the controlled release of therapeutic agents. The gel's unique properties enable it to be sprayable and to harden upon contact with the tissue, setting a new standard in localized drug delivery systems.

Career Highlights

Throughout his career, Zanella has worked with distinguished companies such as Warsaw Orthopedic, Inc. and Medtronic, Inc., further showcasing his expertise in the medical device and pharmaceutical fields. His work has consistently focused on improving patient outcomes through innovation and practical applications of his research.

Collaborations

Zanella has also collaborated with esteemed coworkers, including William F. McKay and Vanja Margareta King. These partnerships have contributed to the success of his inventions and the advancement of methodologies in pain management.

Conclusion

John Myers Zanella's relentless pursuit of innovation has led to groundbreaking advancements in pain relief treatments. His 31 patents stand as a testament to his ingenuity and dedication to improving the quality of life for patients suffering from chronic pain conditions. As the field continues to evolve, Zanella's contributions are sure to inspire future developments in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…